Johnson & Johnson (JNJ): Rep. Josh Gottheimer (NJ05) disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

13 days

Disclosure lag

Traded

Nov 22, 2024

Disclosed

Dec 5, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Oct 29, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
3. Nov 8, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
4. Nov 22, 2024 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

1. Nov 25, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Nov 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
4. Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
5. Dec 12, 2024InsiderDirector purchased ~$147K of JNJ shares in the open market
6. Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
7. Dec 24, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
8. Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
9. Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
10. Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
11. Jan 17, 2025FDAFDA drug approval: Spravato
12. Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
13. Jan 22, 2025FDAFDA device clearance: EMPHASYS Acetabular System
14. Jan 23, 2025FDAFDA drug approval: Darzalex
15. Jan 23, 2025FDAFDA device clearance: MONARCH™ Platform (MON-000008)
16. Jan 24, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
17. Feb 5, 2025FDAFDA device clearance: GRYPHON™ X Anchor; HEALIX TRANSTEND™ Anchor
18. Feb 7, 2025InsiderCFO sold ~$2M of JNJ shares in the open market
19. Feb 18, 2025InsiderChair sold ~$63K of JNJ shares in the open market
20. Feb 24, 2025FDARecall: COR Disposable Kit, 8 mm. Cartilage Transplant System.

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Josh Gottheimer (NJ05)

• House Clerk periodic transaction report at Applied Materials (AMAT)Oct 7, 2026
• House Clerk periodic transaction report at McDonald's (MCD)Oct 7, 2026
• House Clerk periodic transaction report at Applied Materials (AMAT)Sep 14, 2026
• House Clerk periodic transaction report at Microsoft (MSFT)Sep 14, 2026
• House Clerk periodic transaction report at Microsoft (MSFT)Sep 14, 2026

The full history of Rep. Josh Gottheimer (NJ05) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 24, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026

Everything OQRO holds on this company is on its JNJ page.